Sullivan R - Search Results

1

Trends in drug revenue among major pharmaceutical companies: A 2010-2019 cohort study.

Meyers DE, Meyers BS, Chisamore TM, Wright K, Gyawali B, Prasad V, Sullivan R, Booth CM. Meyers DE, et al. Among authors: sullivan r. Cancer. 2022 Jan 15;128(2):311-316. doi: 10.1002/cncr.33934. Epub 2021 Oct 6. Cancer. 2022. PMID: 34614198 Free article.

2

Do Contemporary Randomized Controlled Trials Meet ESMO Thresholds for Meaningful Clinical Benefit?

Del Paggio JC, Azariah B, Sullivan R, Hopman WM, James FV, Roshni S, Tannock IF, Booth CM. Del Paggio JC, et al. Among authors: sullivan r. Ann Oncol. 2017 Jan 1;28(1):157-162. doi: 10.1093/annonc/mdw538. Ann Oncol. 2017. PMID: 27742650 Free article.

3

Economics of Cancer Medicines: For Whose Benefit?

Gyawali B, Sullivan R. Gyawali B, et al. Among authors: sullivan r. New Bioeth. 2017 Apr;23(1):95-104. doi: 10.1080/20502877.2017.1314885. New Bioeth. 2017. PMID: 28517989

4

Delivery of meaningful cancer care: a retrospective cohort study assessing cost and benefit with the ASCO and ESMO frameworks.

Del Paggio JC, Sullivan R, Schrag D, Hopman WM, Azariah B, Pramesh CS, Tannock IF, Booth CM. Del Paggio JC, et al. Among authors: sullivan r. Lancet Oncol. 2017 Jul;18(7):887-894. doi: 10.1016/S1470-2045(17)30415-1. Epub 2017 Jun 2. Lancet Oncol. 2017. PMID: 28583794

5

Five years of EMA-approved systemic cancer therapies for solid tumours-a comparison of two thresholds for meaningful clinical benefit.

Grössmann N, Del Paggio JC, Wolf S, Sullivan R, Booth CM, Rosian K, Emprechtinger R, Wild C. Grössmann N, et al. Among authors: sullivan r. Eur J Cancer. 2017 Sep;82:66-71. doi: 10.1016/j.ejca.2017.05.029. Epub 2017 Jul 10. Eur J Cancer. 2017. PMID: 28648700 Free article.

6

Cancer patients need better care, not just more technology.

Sullivan R, Pramesh CS, Booth CM. Sullivan R, et al. Nature. 2017 Sep 19;549(7672):325-328. doi: 10.1038/549325a. Nature. 2017. PMID: 28933447 No abstract available.

7

Re-aligning the ASCO and ESMO clinical benefit frameworks for modern cancer therapies.

Del Paggio JC, Sullivan R, Hopman WM, Booth CM. Del Paggio JC, et al. Among authors: sullivan r. Ann Oncol. 2018 Mar 1;29(3):773-774. doi: 10.1093/annonc/mdx721. Ann Oncol. 2018. PMID: 29112709 Free article. No abstract available.

8

Targeting the value of targeted therapy.

Paggio JCD, Sullivan R, Booth CM. Paggio JCD, et al. Among authors: sullivan r. Oncotarget. 2017 Oct 7;8(53):90612-90613. doi: 10.18632/oncotarget.21596. eCollection 2017 Oct 31. Oncotarget. 2017. PMID: 29207580 Free PMC article. No abstract available.

9

Delivery of Global Cancer Care: An International Study of Medical Oncology Workload.

Fundytus A, Sullivan R, Vanderpuye V, Seruga B, Lopes G, Hammad N, Sengar M, Hopman WM, Brundage MD, Booth CM. Fundytus A, et al. Among authors: sullivan r. J Glob Oncol. 2018 Sep;4(4):1-11. doi: 10.1200/JGO.17.00126. Epub 2017 Dec 15. J Glob Oncol. 2018. PMID: 29244632 Free PMC article.

10

Cancer groundshot: going global before going to the moon.

Gyawali B, Sullivan R, Booth CM. Gyawali B, et al. Among authors: sullivan r. Lancet Oncol. 2018 Mar;19(3):288-290. doi: 10.1016/S1470-2045(18)30076-7. Lancet Oncol. 2018. PMID: 29508746 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,351 results

Search Page